Founded in 2003, Modul-Bio specializes in computer solutions for biological sample management with the implementation of barcode systems, Laboratory Information Management Systems (LIMS) and collaborative tools for sharing biological sample collections.
Based in Marseille - France, Modul-Bio has recorded consistent growth, deploying solutions for Biological Resource Centres, national cohort projects, biotechnology and cosmetics firms as well as diagnostic companies. Boasting expertise in computing and biology, the company has earned the recognition of commercial clients, academic clients and hospitals, mainly in France and Europe.
Modul-Bio is a key player on the biobanking software market.
With more than 14 years of existence, Modul-Bio figure with over 250 laboratories using its solutions, making it a key player on the biobanking software market.
Our team consists of experts competent in both computing and biology. Design, programming, database, biocomputing, software architecture, systems and network administration and project management are all areas we are skilled in, allowing us to design and enhance high-performance, quality solutions tailored to your activity.
Commitment, team spirit and interaction are strong values that we share and uphold every day in the support and services we offer our clients.
Laurent JACOTOT, robotics engineer, is the co-founder and CEO of Modul-Bio. With over fifteen years of expertise gained in process automation and databases applied to biology, he has particularly worked in Boston on the Human Genome Project (HGP) at the Center for Genome Research Whitehead Institute (MIT), at the Dana Farber Cancer Institute (Harvard Medical School) and at Genomics Collaborative (BioServe), a private biobank.
Philippe VAGLIO, Ph.D.
Scientific Director, co-founder
Philippe VAGLIO holds a Ph.D in Biochemistry from Montpellier University and is an expert in the development of software and databases for scientific applications. He was in charge of bioinformatics group in Marc Vidal’s laboratory at the Dana Farber Cancer Institute – Harvard Medical School (Boston USA) where he took part in creating analysis software and databases for the cloning and two-hybrid screening of Caenorhabditis elegans Open Reading Frames (ORF). He was previously responsible for implementing a LIMS for anti-infective molecules screening for RiboTargets in Cambridge, UK.